Immediate Impact

3 by Nobel laureates 16 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
2024 Standout
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
2 intermediate papers

Works of Vikram Kansra being referenced

Final results of the phase I trial of niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor incorporating proof of concept biomarker studies and expansion cohorts involving BRCA1/2 mutation carriers, sporadic ovarian, and castration resistant prostate cancer (CRPC).
2013
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
2013

Author Peers

Author Last Decade Papers Cites
Vikram Kansra 334 409 189 196 52 1.2k
Tadahito Shimada 222 523 377 320 48 1.3k
Xiaohong Peng 219 578 118 200 58 1.3k
Kumaravelu Jagavelu 210 600 173 254 57 1.4k
Lingling Liu 258 617 127 114 78 1.2k
Florent Martin 324 570 100 155 38 1.4k
Yoko Yamagiwa 212 402 240 222 38 992
Shinobu Miyazaki‐Anzai 289 430 286 158 30 1.3k
Mary Ellen Cvijic 313 479 95 280 59 1.4k
Hailin Zhang 195 527 64 118 56 1.0k
Tetsuro Sano 274 701 140 214 49 1.4k

All Works

Loading papers...

Rankless by CCL
2026